
Dec 23 (Reuters) - A patient who was being treated with Pfizer's hemophilia drug, Hympavzi, as part of a long-term study died after experiencing serious side effects, the company said.
The individual died on December 14 after suffering a stroke followed by a brain hemorrhage, according to the European Haemophilia Consortium, a patient support group.
The patient was enrolled in a study that was testing Hympavzi in patients with hemophilia A or B with or without inhibitors.
"Pfizer, together with the trial investigator and the independent external Data Monitoring Committee, are actively gathering information to better understand the complex, multi-factorial circumstances surrounding this occurrence," the company said in a statement.
The therapy, a once-a-week injection, gained U.S. approval last year to prevent or reduce bleeding episodes in hemophilia A or B patients aged 12 years and older by targeting blood-clotting proteins.
Pfizer does not anticipate any impact to safety for patients treated with the drug based on its current knowledge and the overall clinical data collected to date, the company said.
People with hemophilia have a defect in a gene that regulates the production of proteins called clotting factors, causing spontaneous and severe bleeding following injuries or surgery.
Earlier this year, Pfizer said it would halt global development and commercialization of its hemophilia gene therapy, Beqvez, citing soft demand from patients and their doctors.
Beqvez, a one-time therapy, was approved in the U.S. for the treatment of adults with moderate to severe hemophilia B.
(Reporting by Sneha S K in Bengaluru; Editing by Anil D'Silva)
latest_posts
- 1
Mont Blanc road tunnel reopens to traffic after 15 weeks of repairs - 2
Figure out How to Amplify the Resale Worth of Your Kona SUV - 3
Step into Nature: A Survey of \Handling Trails with Solace\ Climbing Shoes - 4
Watch This Glacier Race into the Sea - 5
Chemical leak in Oklahoma forces evacuations and leaves many ill
Former ‘Dancing with the Stars’ Pro Survives Plane Crash at LaGuardia That Left 2 Pilots Dead
Trump administration plan to reduce access to some student loans angers nurses, health care groups
New dinosaur tracks in Italy illustrate herds moving in unison
Somaliland denies trading recognition with Israel for accepting Gazans
Scientists are getting our robotic explorers ready to help send humans to Mars
New science points to 4 distinct types of autism
Climate engineering would alter the oceans, reshaping marine life – our new study examines each method’s risks
10 Asian Countries Perfect for Solo Female Travelers
The most effective method to Perceive the Early Side effects of Cellular breakdown in the lungs













